Envista Holdings Corp
NYSE:NVST
Envista Holdings Corp
Stock-Based Compensation
Envista Holdings Corp
Stock-Based Compensation Peer Comparison
Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors
Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
E
|
Envista Holdings Corp
NYSE:NVST
|
Stock-Based Compensation
$30.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
Boston Scientific Corp
NYSE:BSX
|
Stock-Based Compensation
$241m
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Stock-Based Compensation
$218m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
Abbott Laboratories
NYSE:ABT
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Stock-Based Compensation
$606.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Stock-Based Compensation
$80.2m
|
CAGR 3-Years
81%
|
CAGR 5-Years
116%
|
CAGR 10-Years
N/A
|
See Also
What is Envista Holdings Corp's Stock-Based Compensation?
Stock-Based Compensation
30.7m
USD
Based on the financial report for Dec 31, 2023, Envista Holdings Corp's Stock-Based Compensation amounts to 30.7m USD.
What is Envista Holdings Corp's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
18%
Over the last year, the Stock-Based Compensation growth was 1%. The average annual Stock-Based Compensation growth rates for Envista Holdings Corp have been 11% over the past three years , 18% over the past five years .